Thursday, June 20, 2013 11:35:20 AM  SENSEX  18860.55  Down  -385.15      B H E L :   176.75  Down  -3.55      Bajaj Auto :   1829.10  Down  -6.20      Bharti Airtel :   290.00  Down  -9.70      Cipla :   377.25  Down  -2.60      Coal India :   294.80  Down  -4.90      Dr Reddy's Labs :   2085.00  Down  -14.50      GAIL (India) :   293.00  Down  -4.05      H D F C :   820.70  Down  -22.00      HDFC Bank :   644.30  Down  -20.75      Hero Motocorp :   1609.00  Down  -10.60      Hind. Unilever :   594.70  Down  -0.05      Hindalco Inds. :   98.05  Down  -6.15      ICICI Bank :   1044.85  Down  -41.60      Infosys :   2435.00  Down  -3.00      ITC :   322.30  Down  -7.80      Jindal Steel :   229.50  Down  -16.30      Larsen & Toubro :   1405.90  Down  -31.50      M & M :   954.00  Down  -24.60      Maruti Suzuki :   1509.90  Down  -34.30      NTPC :   141.15  Down  -3.80      O N G C :   301.80  Down  -6.90      Reliance Inds. :   809.30  Down  -21.80      St Bk of India :   2008.00  Down  -37.70      Sterlite Inds. :   81.80  Down  -3.45      Sun Pharma.Inds. :   982.05  Up  20.90      Tata Motors :   286.40  Down  -5.35      Tata Power Co. :   82.00  Down  -0.60      Tata Steel :   275.60  Down  -14.95      TCS :   1432.35  Up  3.25      Wipro :   344.80  Up  1.75    
GET QUOTES NAV NEWS
SENSEX
18860.55
-385.15
NIFTY
5696.5
-125.75
GOLD
27818
-193.00
SILVER
43473
-481.00
equities
Daily Market Tracker
Gainers & Losers  
Live Indices  
Index Movers  
Advances & Declines  
Val & Vol Toppers  
Only Buyers/Sellers  
Sector Watch  
Bulk Deals  
Block Deals  
New Highs & Lows  
52 Week High Low  
Out/Under Performers
Index Constituents  
Unusual Volume  
Historical Returns  
News Analysis
Market Analysis
Technical Chart
Company Profile
Other Markets
Corporate Action
Debt Content
Submit Your Query
You Are Here : Markets  |  Equity   |   Company Profile  |   Reports
Brooks Laboratories Ltd(Industry :   Pharmaceuticals - Indian - Bulk Drugs & Formln)
 
BSE Code:533543NSE Symbol: BROOKSP/E  (TTM): 2.23013
ISIN Demat:INE650L01011Div Yield %:0EPS   (TTM) ( Cr.) :8.43
Book Value ( Cr.):64.8Market Cap ( Cr.):30.4372Face Value ( Cr.) :10
  Change Company 



Notes To The Financial Statements





SCHEDULE - XXI

A) SIGNIFICANT ACCOUNTING POLICIES

1. ACCOUNTING CONVENTION

The Financial Statements are prepared in accordance with applicable Accounting Standards in India. A summary of important Accounting Policies, which have been applies consistently, is set out below. Accounting Policies comprises Accounting Standards specified by Central Government u/s 211 (3C) of the companies Act 1956, other pronouncements of the Institute of Chartered Accountants of India and guidelines issued by SEBL. The Financial Statements have also been prepared in accordance with relevant presentational requirements of Companies Act 1956. The Financial Statements are rounded to the nearest Rupees.

2. BASIS OF ACCOUNTING

The accounts are prepared under the historical cost convention and on the basis of going concern. All expenses and incomes to the extent ascertainable are accounted for on mercantile basis unless otherwise stated.

3. USE OF ESTIMATES.

The presentation of financial statements requires estimates and assumptions to be made that affect the reported amount of assets and liabilities on the date of financial statements and the reported amount of revenue and expenses during the reporting period. Difference between the actual results and estimates are recognized in the period in which the results are known/materialized.

4. FIXED ASSETS

Fixed Assets are stated at historical cost (including expenses incurred on putting them in use less depreciation.

5. DEPRECIATION

Depreciation has been provided on straight -line method, on single shift basis at the rates specified in the schedule XIV of the Companies Act, 1956.

6. INVENTORIES

The inventories are valued in accordance, with the revised Accounting Standard-2 "(AS-2)" Valuation of Inventories" and the revised " Guidance Note on Accounting Treatment for Excise Duty" issued by the Institute of Chartered Accountants of India. According the method of valuation adopted are as under :-

i. Stock Raw Material and Packing Material :- At cost price.

ii. Stock of Work in Progress :- At material cost plus apportioned manufacturing overheads.

iii. Stock of Finished Goods :- At material cost plus apportioned manufacturing overheads plus excise duty and other costs incurred in brining the inventories to their present location and condition or Net Realizable value whichever is lower.

iv. Spares and consumable :- At cost.

7. INVESTMENTS

(a) Long term Investments are stated at cost of acquisition, provision for diminution is made only to recognize a decline other than temporary, if any, in the value of investments.

(b) Current investments are carried at lower of cost and fair market value.

(c) Dividends are accounted for as and when received.

8. RETIREMENT BENEFITS

(a) A short term employees benefits are recognized as an expenses at the undiscounted amount in the profit and loss accounts of the year in which the related is rendered.

(b) Post employees and other long term employees benefits are recognized as an expense in the profit and loss account for the year in which the employees has rendered services. The expenses is recognized at the present value of the amount payable determined using actuation techniques. Actuarial gains and losses in respect of post employment and other long term benefits are charged to profit and loss account.

9. PROPOSED DIVIDEND

Dividends (including income tax thereon) as proposed by Board of Directors are provided in the books of account, pending approval at the Annual General Meeting.

10. REVENE RECOGNITION

Sales of goods and services are recognized upon passage of the title to the customer, which generally coincides with the delivery. Sale is net of sale returns

11. BORROWING COSTS

Borrowing costs that are attributable to the acquisition or construction of fixed assets are capitalized as part of costs of such assets till such time as the assets is ready for its intended use. All other borrowing costs are recognized as an expense in the period in which incurred.

12. TRANSLATION OF FOREIGN EXCHANGE TRANSACTIONS

(a) Foreign exchange transactions in respect of import payments are stated at the exchange rate prevailing at the time of transaction and variation, if any, accounted for on the date of payment is squared during the same accounting year.

(b) Monetary items denominated in foreign currencies remaining unsettled at the year end-if not covered by forward exchange contracts are translated at year end rates.

(c) Any income / expense arising from foreign currency transactions is dealt in the profit and loss account for the year except in cases where they relate to acquisition of fixed assets in which case they are adjusted in the carrying cost of such assets.

13. INCOME TAX

(a) Current Tax: Provision is made for income tax based on the liability as computed after taking credit for allowance and exemptions. Adjustments in books are made only after the completion of the assessment.

(b) Deferred Tax : Consequent to the Accounting Standard 22 "Accounting for taxes on income" the differences mat result between the profit offered for income tax and the profit as per the financial statement are identified and thereafter a deferred tax liability is recorded for timing differences, namely the differences that originate is one accounting period and reverse in another.

The tax effect is calculated on the accumulated timing difference at the end of an Accounting period based on prevailing enacted regulations,

Deferred tax assets are recognized only if there is reasonable certainty that they will be realized and are reviewed for the appropriateness of their respective carrying value at each balance sheet date.

(c) MAT: Minimum Alternative Tax payable under the provisions of the income tax Act, 1961 is recognized as an asset in the year in which credit becomes eligible and is set off in the year in which the Company becomes liable to pay income taxes at the enacted tax rates and shall be reversed in the year in which It lapses.

14. AMORTISATION OF INTANGIBLE ASSETS AND MISCELLANCE EXPENDITURE

Preliminary expenses are amortized over a period of five years. Listing expenses and Initial public offer expenses are also incurred during the year. All these expenses will be written off over the period of next five years starting from the year of public issue.

15. PROVISIONS, CONTINGENT LIABILITIES AND CONTIGENT ASSETS

Provisions involving substantial degree of estimation in management are recognized when there is present obligation as a result of past events and it is probable that there will be an outflow of resources. Contingent Liabilities are not recognized but are disclosed in the notes. Contingent Assets are neither recognized nor disclosed in the financial statements.

16. IMPAIREMENT OF ASSETS

An assets is treated as impaired when the carrying cost of assets exceeds its recoverable value. An impairment loss is charged to the profit & loss account in the year in which an assets is identified as impaired. The impairment loss recognized in prior accounting periods is reversed if there has been a change in the estimate of recoverable amount: Accounting policies not specially referred to are consistent with generally accepted accounting principals.

17. FORWARD EXCHANGE CONTRACT

A company may enter into a forward exchange contract or another financial Instrument that is in substance a forward exchange contract, Which are not intended for trading or speculation purposes, to establish the amount of the reporting currency required or available at the settlement date of the traction. As per AS-11 (R) any premiums or discount at the inception of such a forward exchange contract are amortized over the life of the contract and exchange difference on such contracts are recognized in the statement of profit or loss in the reporting period.

18. In accordance with the guidance notes of the ICAI, the company has recognized minimum alternative tax of Rs. 1,31,33,587 relating to the current year.

(B) NOTES ON ACCOUNTS

1. The figures for the year have been re-grouped / rearranged /re-cast wherever necessary market it comparable.

2. The company has sent letters of balance confirmation to all the parties but only a few have responded so far. So the balance in the party accounts whether in debit or in credit are subject to reconciliation.

3. DIRECTOR'S REMUNERATION

- Current year Previous Year
(Rs.) (Rs.)
Salary (Gross) 34,20,200 16,92,000
34,20,200 16,92,000

4. AUDITOR'S REMUNERATION

Current year Previous Year
(Rs.) (Rs.)
Statutory Audit Fees 1,75,000 1,00,000
Tax Audit Fee 50,000 30,000
Management Matters 25,000 30,000
Add: Service tax 25,750 13,390
Total 2,75,750 1,73,390

5. A sum of Rs. 69,125 (Previous Year Rs.1,15,125 ) is due from Staff of the company being imprest for traveling, conveyance and other charges.

6. Fixed deposits with banks of Rs. 60,99,000.00 (previous year Rs. 78,42,256) as pledged as Margin Money with banks.

7. Remittance in foreign currency on account of Dividend is NIL (P/Y NIL)

8. Disclosure as required by AS-18 (Related Party Disclosures) issued by ICAI.

Related Party Relationship Nature of Transaction Amount of Transaction
Mr. Rajesh Mahajan Managing Director Remuneration Paid INR 13,80,000
Mr Atul Ranchal Chairman Remuneration Paid INR 13,80,000
Mr DS Maity Director Remuneration Paid. INR 5,34,200
Mr. Ram Partap Director Remuneration Paid INR 63,000
Mr Manmohan Director Remuneration Paid INR 63,000
Mrs, Saras Gapta Director's Wife Remuneration Paid INR 5,76,000
Mrs. Rajni Ranchal Director's Wife Remuneration Paid INR 5,76,000

7. EARNING PER SHARE (EPS)

Current Year Previous Year
PAT Rs. 6,88,82,063 Rs. 5,17,19,642
Weighted Average Number of Ordinary Shares 9,886,421 4,651,200
Weighted Average Number of Diluted Shares 9,840,207 9,800,330
Basic EPS 6.97 11.12
Diluted EPS 7.00 5.28

8. The company operates only in one business segment viz. "Pharmaceutical Formulation" and is engaged in manufacturing and trading of medicines. Since in the opinion of management, the inherent nature of activities "engaged by the company are governed by the same set of risks and rewards, so these have been grouped and identified as a single segment in accordance with the Accounting Standard on Segment Reporting (AS-17) issued by ICAI.

9. In the opinion of the board, and to the best of their knowledge and belief the value on realization of the current assets, loans & advance shown in the Balance Sheet in the ordinary course of business will be at least equal to the amount at which they are stated in the Balance Sheet and provision for all known and determined liabilities has been made.

10. Some of suppliers of material have been identified as small scale industrial undertaking on the basis of information available with the company. However none of these parties has an outstanding credit balance exceeding Rs, 1,00,000.00 as on 31.03.2011

11. Contingent Liabilities:.

(Not provided for in the books of accounts)

Current Year Previous Year
(a) Letter of Credit outstanding (Appx. Rs 233.64 lacs) 5.24 Lacs -

12. During the year, the company has undertaken a review of all fixed assets in line with the requirements of AS-28 on "Impairment of Assets" issued by the Institute of Chartered Accountant of India. Based on such review, no provision for impairment is required to be recognized for the year.

13. The figures in the Balance Sheet and Profit & Loss Account for the year have been rounded off to nearest multiple of rupee.

14. The company has provided a Provision for gratuity and leave encasement as per valuation which was done as required under accounting standard (AS-15) "accounting for retirement benefits" by an independent Actuarian valuer.

15. Additional information pursuant to the provision of paragraph 3, 4C & 4D of Part II of schedule VI of the Companies Act, 1956. (as certified by the management)

i) Licensed Capacity

Sr. No. Particulars Units Licensed Capacity (p.a.) 2010-11 Licensed Capacity (p.a.) 2009-10
1. Dry Syrup Nos. 120 lacs 120 lacs
2. Tablets Box 2400 lacs 2400 lacs
3. Injections Nos 333 lacs 333 lacs

ii) Installed Capacity (as certified by management)

Sr. No. Particulars Units Installed Capacity (p.a.) 2010-11 Installed Capacity (p.a) 2009-10
1. Dry Syrup Nos. 120 lacs 120 lacs
2, Tablets Box 1200 lacs 1200 lacs
3. Injections Nos 300 lacs 300 lacs

iii) Detail of Prediction / Purchases, Sales and Closing Stock for the year 2010-11

Sr. NO. GROUP UNIT YEAR PROD. (In lacs)

OPENING STOCK

CLOSING STOCK

SALE

QTY (In lacs) VALUE (In lacs) QTY (In lacs) VALUE (In lacs) QTY (In lacs) VALUE (In lacs)
1. Dry Syrup S. No. 2010-11 60.07 4.77 69.13 0.46 6.54 60.55 860.00
2009-10 18.72 4.3 62.38 4.77 69.13 18.26 262.38
2 Tablets Boxes 2010-11 223.72 4.94 7.16 1.33 4.02 235.42 952.44
2009-10 13.22 3.36 4.86 4.94 7.16 11.63 803.00
3. Injections No. 2010-11 243.00 31.12 171.16 5.2 63.95 248.00 3441.47
- 2009-10 199.78 28.62 171.74 31.12 171.16 197.28 3357.42
Other No. 2010-11 NIL 2.4 12 NIL NIL NIL NIL
2009-10 1.82 2.37 9.49 2.4 12 1.8 84.04

iv) Detail of Maw Material Consumption

Particular 2010-11 2009-10
Value Value
(In Rs.) (In Rs.)
1. Dry Syrup 61060510 23146952
2. Tablets 67623287 57083699
3. Injections 244344296 239755516

v) CIF Value of Imports

Particulars Currency 2010-11 2009-10
Raw Material INR 9,91,06,901 8,16,10,618
Capital Goods INR - -

 

vi) Expenditure in Foreign Currency : Rs. 2,04,608/-
vii) Earnings in Foreign Exchange: Nil

 

Auditors' Report
In term of our separate report of even date annexed here to.
for J. K. & ASSOCIATES For and on behalf of Board of Directors
Chartered Accountants

 

Rajesh Mahajan Atul Ranchal
(Director) (Director)
(J. K. JAIN)
Place: Chandigarh
Date: 13.06.2011
   
  A    |   B   |   C    |  D    |    E    |  F  |    G   |   H  |  I  |    J   |   K  |   L  |    M  |   N  |   O  |   P  |  Q  |  R  |  S  |  T   |  U   |   V   |    W   |  X   |  Y  |    Z
SEBI Regn. No. NSE: INB/INF/INE 230881235   |   BSE: INB/INF/INE 010881234   |   DSE: INB 050881235   |   MCX-SX : INE 260881235  |   USE - INE 270881235   |   NSDL- DP ID: IN-DP-NSDL-14-96   |   CDSL DP ID: IN-ID-CDSL-43-99         Commodity Membership No.: MCX-10705, NCDEX-0016, NMCE-CL0044, NSPOT-10002, NSEL-10700, SNX-2255, ICEX-1025   |   Dubai Gold and Commodity Exchange (DGCX)-3035   |   Indian Energy Exchange (IEX)- Electricity Trading N2DLOAIL0000
Copyright@2012 Alankit . All rights reserved. Designed, developed and powered by C-MOTS Infotech (ISO 9001:2008 certified)